Kitamura Misa, Okano Hiromu, Jujo Satoshi, Ishii Kenji, Aoki Kazuhiro, Okamoto Hiroshi
Department of Internal Medicine, St. Luke's International Hospital, Tokyo, JPN.
Department of Social Medical Sciences, Graduate School of Medicine, International University of Health and Welfare, Tokyo, JPN.
Cureus. 2024 Dec 31;16(12):e76657. doi: 10.7759/cureus.76657. eCollection 2024 Dec.
Systemic capillary leak syndrome (SCLS) is a rare and life-threatening disorder characterized by acute hypotension, hypoalbuminemia, and hemoconcentration, which often results in severe respiratory complications, such as pulmonary edema. SCLS can be triggered by infections, including COVID-19, and is associated with a high mortality rate. Here, we report a case of COVID-19-associated SCLS in a 68-year-old man. After aggressive fluid resuscitation, the patient's respiratory failure worsened. Veno-venous extracorporeal membrane oxygenation (V-V ECMO) was initiated early because of rapidly declining oxygenation (PaO/FiO=58) and pulmonary compromise. V-V ECMO successfully supported respiratory and circulatory functions and stabilized the patient. The patient was successfully weaned from ECMO on day 10 and later discharged from the ICU in stable condition. This case highlights the potential benefits of early ECMO intervention and controlled fluid resuscitation in managing COVID-19-associated SCLS.
系统性毛细血管渗漏综合征(SCLS)是一种罕见的、危及生命的疾病,其特征为急性低血压、低白蛋白血症和血液浓缩,常导致严重的呼吸并发症,如肺水肿。SCLS可由包括新型冠状病毒肺炎(COVID-19)在内的感染引发,且死亡率很高。在此,我们报告一例68岁男性COVID-19相关SCLS病例。在积极进行液体复苏后,患者的呼吸衰竭恶化。由于氧合迅速下降(动脉血氧分压/吸入氧分数值[PaO/FiO]=58)和肺部功能受损,早期启动了静脉-静脉体外膜肺氧合(V-V ECMO)。V-V ECMO成功支持了呼吸和循环功能并使患者病情稳定。患者在第10天成功脱离ECMO,随后从重症监护病房(ICU)平稳出院。该病例凸显了早期ECMO干预和控制性液体复苏在治疗COVID-19相关SCLS中的潜在益处。